Chemical Works of Gedeon Richter (RGEDF) Gets a Buy from Berenberg Bank

In a report released yesterday, Victoria Lambert from Berenberg Bank maintained a Buy rating on Chemical Works of Gedeon Richter (RGEDF – Research Report), with a price target of Ft11,675.00. The company’s shares closed last Monday at $28.19.

According to TipRanks, Lambert is a 4-star analyst with an average return of 7.7% and a 78.85% success rate.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Chemical Works of Gedeon Richter with a $4,572.60 average price target, a 16,120.65% upside from current levels. In a report released yesterday, RBC Capital also maintained a Buy rating on the stock with a C$12,400.00 price target.

The company has a one-year high of $30.14 and a one-year low of $20.67. Currently, Chemical Works of Gedeon Richter has an average volume of 2.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Chemical Works of Gedeon Richter (RGEDF) Company Description:

The Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale and Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale and Retail segment represents the distribution chain in the market which facilitate the product reaching the final buyers. The Other segment relates to the business of the members of the group that do not belong to any of the segments. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.